{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:14:44Z","timestamp":1788315284640,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-025-10311-4","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:47:06Z","timestamp":1768092426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Opioid-induced neurotoxicity after opioid conversion to methadone in patients with cancer pain using the stop-and-go method: A multicenter retrospective cohort study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-0087","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Calsina-Berna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-2102","authenticated-orcid":false,"given":"Jes\u00fas","family":"Gonz\u00e1lez-Barboteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-971X","authenticated-orcid":false,"given":"Anna","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-4842","authenticated-orcid":false,"given":"Silvia","family":"Llorens Torrom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-5979","authenticated-orcid":false,"given":"Gemma","family":"Sanclemente Juarros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1056-2245","authenticated-orcid":false,"given":"Montserrat","family":"Bleda P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0854-8825","authenticated-orcid":false,"given":"Irene","family":"Carr\u00e9 Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9082-707X","authenticated-orcid":false,"given":"Margarita","family":"Alvaro Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7671-3777","authenticated-orcid":false,"given":"Lina","family":"Maria Nitola Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2158-2978","authenticated-orcid":false,"given":"Paula","family":"Garrido Ballart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7701-8645","authenticated-orcid":false,"given":"Roser","family":"Cuadros-Margarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0004-5829","authenticated-orcid":false,"given":"Montse","family":"Olmo Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8422-5009","authenticated-orcid":false,"given":"Claudia","family":"Andrea Cruz Sequeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3523-0370","authenticated-orcid":false,"given":"Maria","family":"Labori Trias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Cuenca-Casbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bavestrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alcalde Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1503-385X","authenticated-orcid":false,"given":"Ignacio","family":"Borque Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1462-3167","authenticated-orcid":false,"given":"Joaquim","family":"Juli\u00e0-Torras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"issue":"9","key":"10311_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MHJ van den Beuken- Everdingen","year":"2007","unstructured":"van den Beuken- Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437\u20131449","journal-title":"Ann Oncol"},{"issue":"3","key":"10311_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030591","volume":"15","author":"RAH Snijders","year":"2023","unstructured":"Snijders RAH, Brom L, Theunissen M, van den Beuken- Everdingen MHJ (2023) Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers 15(3):591","journal-title":"Cancers"},{"issue":"3","key":"10311_CR3","first-page":"243","volume":"33","author":"MP Davis","year":"2025","unstructured":"Davis MP, Davies A, McPherson ML, Reddy AS, Paice JA, Roeland EJ et al (2025) Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline. Support Care Cancer 33(3):243","journal-title":"Support Care Cancer"},{"issue":"10","key":"10311_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s11864-023-01117-9","volume":"24","author":"S Mercadante","year":"2023","unstructured":"Mercadante S (2023) Opioid-induced neurotoxicity in patients with cancer pain. Curr Treat Options Oncol 24(10):1367\u20131377","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"10311_CR5","first-page":"542","volume":"32","author":"MP Davis","year":"2024","unstructured":"Davis MP, Davies A, McPherson ML, Reddy A, Paice JA, Roeland E et al (2024) Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline. Support Care Cancer 32(8):542","journal-title":"Support Care Cancer"},{"issue":"3","key":"10311_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jpainsymman.2017.10.017","volume":"55","author":"S Mercadante","year":"2018","unstructured":"Mercadante S, Bruera E (2018) Methadone as a first-line opioid in cancer pain management: a systematic review. J Pain Symptom Manage 55(3):998\u20131003","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10311_CR7","first-page":"CD003971","volume":"2017","author":"AB Nicholson","year":"2017","unstructured":"Nicholson AB, Watson GR, Derry S, Wiffen PJ (2017) Methadone for cancer pain. Cochrane Database Syst Rev 2017(2):CD003971","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10311_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/15360288.2014.938883","volume":"28","author":"P Good","year":"2014","unstructured":"Good P, Afsharimani B, Movva R, Haywood A, Khan S, Hardy J (2014) Therapeutic challenges in cancer pain management: a systematic review of methadone. J Pain Palliat Care Pharmacother 28(3):197\u2013205","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"4","key":"10311_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","volume":"15","author":"R Chou","year":"2014","unstructured":"Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC et al (2014) Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain 15(4):321\u2013337","journal-title":"J Pain"},{"key":"10311_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejca.2016.08.028","volume":"68","author":"X Ruan","year":"2016","unstructured":"Ruan X, Luo JJ, Kaye AD (2016) Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. Eur J Cancer 68:199\u2013200","journal-title":"Eur J Cancer"},{"issue":"2","key":"10311_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0885-3924(99)00049-4","volume":"18","author":"B Gagnon","year":"1999","unstructured":"Gagnon B, Bruera E (1999) Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. J Pain Symptom Manage 18(2):120\u2013125","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"10311_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1742-1241.2008.01990.x","volume":"63","author":"W Leppert","year":"2009","unstructured":"Leppert W (2009) The role of methadone in cancer pain treatment: a review. Int J Clin Pract 63(7):1095\u20131109","journal-title":"Int J Clin Pract"},{"issue":"10","key":"10311_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1089\/jpm.2022.0266","volume":"25","author":"A Reddy","year":"2022","unstructured":"Reddy A, Sinclair C, Crawford GB, Mcpherson ML, Mercadante S, Hui D et al (2022) Opioid rotation and conversion ratios used by palliative care professionals: an international survey. J Palliat Med 25(10):1557\u20131562","journal-title":"J Palliat Med"},{"issue":"2","key":"10311_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","volume":"50","author":"S McLean","year":"2015","unstructured":"McLean S, Twomey F (2015) Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manage 50(2):248\u201359.e1","journal-title":"J Pain Symptom Manage"},{"key":"10311_CR15","doi-asserted-by":"crossref","unstructured":"Moksnes K, Dale O, Rosland JH, Paulsen, Klepstad P, Kaasa S (2011) How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trial. Eur J Cancer 47(16):2463\u201370","DOI":"10.1016\/j.ejca.2011.06.047"},{"issue":"13","key":"10311_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.medcli.2010.06.006","volume":"135","author":"J Gonz\u00e1lez-Barboteo","year":"2010","unstructured":"Gonz\u00e1lez-Barboteo J, Trelis-Navarro J, Tuca-Rodr\u00edguez A, G\u00f3mez-Batiste X (2010) Opioid rotation: a therapeutic choice in the management of refractory cancer pain. Med Clin (Barc) 135(13):617\u2013622","journal-title":"Med Clin (Barc)"},{"key":"10311_CR17","unstructured":"Catalan Institute of Oncology (2023) Executive summary [Internet]. Barcelona: Catalan Institute of Oncology; [cited 2025 Sep 11]. Available from: https:\/\/ico.gencat.cat\/web\/.content\/minisite\/ico\/lico\/memories\/ico-resum-executiu-2023-eng.pdf. Accessed 8 Sept 2025"},{"key":"10311_CR18","unstructured":"Alvarez Gracia N, \u00c1lvaro Pardo M, Bavestrello P, Barbero Biedma E, Calsina Berna A, Corcoy de Febrer B et al (2022) ICO-ICS Praxis para el tratamiento del dolor oncol\u00f3gico [Internet]. [cited 2025 Sep 11]. 1\u2013153 p. Available from: https:\/\/ico.gencat.cat\/web\/.content\/minisite\/ico\/professionals\/documents\/arxius\/ICO-ICS-Praxi-Dolor-cast.pdf"},{"key":"10311_CR19","unstructured":"Gonz\u00e1lez-Barboteo J, Porta-Sales, Tratamiento del dolor, Juli\u00e0-Torras J, Serrano-Berm\u00fadez G (2019) eds Manual de control de s\u00edntomas en pacientes con c\u00e1ncer avanzado y terminal, 4th edn. Ar\u00e1n Ediciones, Madrid, p 76-104"},{"key":"10311_CR20","unstructured":"Labori M, Gonz\u00e1lez-Barboteo J, Metadona In, Gonz\u00e1lez-Barboteo J, Juli\u00e0-Torras J, Serrano-Berm\u00fadez G, Porta-Sales J (eds) (2019) Manual de rotaci\u00f3n de opioides en el paciente oncol\u00f3gico, 2nd edn. Canal Editorial, Madrid, p 105-120"},{"issue":"8","key":"10311_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1634\/theoncologist.2015-0503","volume":"21","author":"J Porta-Sales","year":"2016","unstructured":"Porta-Sales J, Garz\u00f3n-Rodr\u00edguez C, Villavicencio-Ch\u00e1vez C, Llorens-Torrom\u00e9 S, Gonz\u00e1lez-Barboteo J (2016) Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist 21(8):981\u2013987","journal-title":"Oncologist"},{"issue":"3","key":"10311_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/jpm.2020.0244","volume":"24","author":"J Gonz\u00e1lez-Barboteo","year":"2021","unstructured":"Gonz\u00e1lez-Barboteo J, Porta-Sales J, Nabal-Vicu\u00f1a M, D\u00edez-Porres L, Canal-Sotelo J, Alonso-Babarro A et al (2021) Switching ratio from parenteral to oral methadone 1:1.2 is safer compared with ratio 1:2 in patients with controlled cancer pain: a multicenter randomized-controlled trial (RATIOMTD-010810). J Palliat Med 24(3):382\u2013390","journal-title":"J Palliat Med"},{"issue":"1","key":"10311_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/15360288.2023.2297218","volume":"38","author":"G Cerd\u00e0","year":"2024","unstructured":"Cerd\u00e0 G, Juli\u00e0-Torras J, Gonz\u00e1lez-Barboteo J, Romeo M, Calsina-Berna A (2024) Polypharmacy and reversible drug-induced QT prolongation in a patient with advanced cancer: case report. J Pain Palliat Care Pharmacother 38(1):33\u201337","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"1","key":"10311_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/A:1008263910494","volume":"9","author":"C Ripamonti","year":"1998","unstructured":"Ripamonti C, De Conno F, Groff L, Belzile M, Pereira J, Hanson J et al (1998) Equianalgesic dose\/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol 9(1):79\u201383","journal-title":"Ann Oncol"},{"issue":"1","key":"10311_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-022-01076-2","volume":"21","author":"H Ding","year":"2022","unstructured":"Ding H, Song Y, Xin W, Sun J, Zhong L, Zhou Q et al (2022) Methadone switching for refractory cancer pain. BMC Palliat Care 21(1):191","journal-title":"BMC Palliat Care"},{"issue":"6","key":"10311_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40122-024-00651-0","volume":"13","author":"L Lei","year":"2024","unstructured":"Lei L, Zhou Q, Liu X, Bao G, Ding H, Ding Q et al (2024) Methadone conversion using a 3-day switch strategy in patients with cancer on high-dose opioids: a retrospective study. Pain Ther 13(6):1499\u20131509","journal-title":"Pain Ther"},{"issue":"10","key":"10311_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5694\/j.1326-5377.2000.tb139323.x","volume":"173","author":"OT Ayonrinde","year":"2000","unstructured":"Ayonrinde OT, Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173(10):536\u2013540","journal-title":"Med J Aust"},{"issue":"5","key":"10311_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jpainsymman.2016.05.022","volume":"52","author":"P Poulain","year":"2016","unstructured":"Poulain P, Berleur MP, Lefki S, Lefebvre D, Chvetzoff G, Serra E et al (2016) Efficacy and safety of two methadone titration methods for the treatment of cancer-related pain: the EQUIMETH2 trial (methadone for cancer-related pain). J Pain Symptom Manage 52(5):626-636.e1","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10311_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1526-4637.2012.01334.x","volume":"13","author":"S Mercadante","year":"2012","unstructured":"Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13(3):399\u2013404","journal-title":"Pain Med"},{"issue":"4","key":"10311_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jpainsymman.2023.04.026","volume":"66","author":"S Mercadante","year":"2023","unstructured":"Mercadante S, Lo Cascio A, Casuccio A (2023) Switching to intravenous methadone in advanced cancer patients: a retrospective analysis. J Pain Symptom Manage 66(4):287\u2013292","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10311_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-023-01163-y","volume":"22","author":"S Mercadante","year":"2023","unstructured":"Mercadante S (2023) A better interpretation of data regarding the opioid switching to methadone. BMC Palliat Care 22(1):65","journal-title":"BMC Palliat Care"},{"issue":"6","key":"10311_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5055\/jom.2014.0236","volume":"10","author":"J Gonz\u00e1lez-Barboteo","year":"2014","unstructured":"Gonz\u00e1lez-Barboteo J, G\u00f3mez-Batiste X, Calvo Manuel FA, Candel VA, Palacio Eito MA, S\u00e1nchez-Magro I et al (2014) Effectiveness of opioid rotation in the control of cancer pain: the ROTODOL study. J Opioid Manag 10(6):395\u2013403","journal-title":"J Opioid Manag"},{"issue":"4","key":"10311_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","volume":"32","author":"S Mercadante","year":"2006","unstructured":"Mercadante S, Bruera E (2006) Opioid switching: a systematic and critical review. Cancer Treat Rev 32(4):304\u2013315","journal-title":"Cancer Treat Rev"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10311-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:05:23Z","timestamp":1771272323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10311-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10311"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10311-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jes\u00fas Gonzalez-Barboteo is associated with affiliation 3 and is his main affiliation.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee for Clinical Research of both hospitals (-CEIm Hospital Universitari de Bellvitge, ref EOMNA045\/22; -CEIm Hospital Germans Trias i Pujol, ref PI-22\u2013052).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}